Breast cancer is the most common cancer among women in Kenya. It accounts for approximately 23.3% of all cancer cases diagnosed among women. Early detection through regular mammograms and self-examinations is crucial for effective treatment.
Cervical cancer is the second most common cancer among women in Kenya, responsible for 19.7% of all female cancer cases. It is closely linked to HPV infection, and vaccination along with regular Pap smears can significantly reduce the risk.
Prostate cancer is the most common cancer among men in Kenya, accounting for 14.4% of all male cancer cases. Early detection through PSA tests and digital rectal exams is vital for successful treatment.
Esophageal cancer is particularly prevalent in certain regions of Kenya, notably among communities that consume hot beverages and tobacco. It represents about 11.7% of all cancer cases in the country.

Join us for the 2nd National Cancer Summit, hosted by the National Cancer Institute of Kenya (NCI-Kenya), from July 27th to 30th, 2025 in Nairobi, Kenya. This crucial event will bring together experts, researchers, and stakeholders to discuss the latest advancements in cancer care, prevention, and policy.

From January 30th to February 5th, NCI-K and its partners will conduct free HPV vaccinations and cervical cancer screenings at various locations across Turkana County.
This initiative, as we commemorate World Cancer Day, aims to raise awareness about cervical cancer prevention and provide accessible healthcare services to underserved populations.